Norges Bank Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Norges Bank acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,266,808 shares of the company’s stock, valued at approximately $596,024,000.

Other large investors also recently modified their holdings of the company. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $26,000. Optima Capital LLC purchased a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $27,000. Godfrey Financial Associates Inc. purchased a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $27,000. Montag A & Associates Inc. boosted its stake in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares in the last quarter. Finally, Maseco LLP purchased a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $29,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Peter J. Arduini acquired 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the purchase, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Mizuho cut their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their target price for the stock from $75.00 to $69.00 in a research note on Thursday, May 21st. Rothschild & Co Redburn cut their target price on GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Piper Sandler cut their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $62.34 on Monday. The firm has a market cap of $28.36 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The business has a 50 day moving average price of $67.68 and a 200-day moving average price of $75.88.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.